Biosimilars Market By Product & Application - Globa...
LONDON , Jan. 7, 2016 /- Various factors have contributed to the rise in demand for biopharmaceutical products such as biologics and biosimilars. Some of these factors include...
LONDON , Jan. 7, 2016 /- Various factors have contributed to the rise in demand for biopharmaceutical products such as biologics and biosimilars. Some of these factors include...
Data from the PRospective Observational cohort Study on patients with Inflammatory bowel disease receiving Therapy with biosimilars (PROSIT-BIO) in patients with ulcerative co...
Although biosimilars have been adopted slowly in Canada, competition is getting much fiercer among some of the biggest drug companies with 2016 expected to be a big year the m...
By Kurt R. Karst – The once nascent biosimilars industry took off in 2015 with the first biosimilar approval (ZARXIO [filgrastim-sndz], which FDA licensed on March 6, 2015 u...
[http://medcitynews.com/2015/12/oncobiologics-raising-50m-for-avastin-humira-biosimilars/] The company is raising $50 million, on top of some $43 million it’s raised this ...
http://medcitynews.com/2015/12/oncobiologics-raising-50m-for-avastin-humira-biosimilars/
India's Aurobindo Pharma is said to be in "advanced talks" with a European company for a $200 million deal that will allow it to acquire permits to market biosimilar drugs for...